ERBB2 and breast cancer: Nevertheless, HER2 analysis of primary, recurrent and metastatic tumor tissue is recommended for therapy decisions and the DEPArrayTM-HER2-FISH workflow could be implemented for a subgroup of BC patients like TNBC patients.